Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 07:08 am Purchase | 2023-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | RTW Investments, LP | 18,505,556 9.800% | 18,505,556 (New Position) | Filing History |
| 2024-02-14 07:08 am Purchase | 2023-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD | RTW Investments, LP | 11,253,551 6.900% | 11,253,551 (New Position) | Filing History |
| 2024-02-14 07:07 am Purchase | 2023-12-31 | 13G | UroGen Pharma Ltd. URGN | RTW Investments, LP | 1,726,808 5.600% | 1,726,808 (New Position) | Filing History |
| 2024-02-14 07:06 am Purchase | 2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO | RTW Investments, LP | 3,592,759 6.400% | 3,592,759 (New Position) | Filing History |
| 2024-02-14 07:06 am Purchase | 2023-12-31 | 13G | Arvinas, Inc. ARVN | RTW Investments, LP | 4,213,483 6.200% | 4,213,483 (New Position) | Filing History |
| 2024-02-14 07:05 am Purchase | 2023-12-31 | 13G | ESSA Pharma Inc. EPIX | RTW Investments, LP | 2,298,662 5.200% | 2,298,662 (New Position) | Filing History |
| 2024-02-14 07:04 am Purchase | 2023-12-31 | 13G | GH Research PLC GHRS | RTW Investments, LP | 3,327,129 6.400% | 3,327,129 (New Position) | Filing History |
| 2024-02-14 07:03 am Purchase | 2023-12-31 | 13G | Pharming Group N.V. PHAR | RTW Investments, LP | 38,496,391 5.800% | 38,496,391 (New Position) | Filing History |
| 2024-02-14 07:02 am Purchase | 2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE | RTW Investments, LP | 2,232,760 6.200% | 2,232,760 (New Position) | Filing History |
| 2024-02-14 07:02 am Purchase | 2023-12-31 | 13G | SAB Biotherapeutics, Inc. SABS | RTW Investments, LP | 9,220,672 9.990% | 9,220,672 (New Position) | Filing History |
| 2024-01-24 08:13 am Purchase | 2024-01-24 | 13D | Avidity Biosciences, Inc. RNA | RTW Investments, LP | 6,701,489 8.400% | 744,931 (+12.51%) | Filing History |
| 2024-01-18 9:20 pm Sale | 2024-01-18 | 13G | CUTERA INC CUTRQ | RTW Investments, LP | 1,817,585 9.110% | -29,011 (-1.57%) | Filing History |
| 2023-12-12 4:19 pm Sale | 2023-12-08 | 13D | DermTech, Inc. DMTKQ | RTW Investments, LP | 0 0.000% | -3,018,666 (Position Closed) | Filing History |
| 2023-11-24 4:15 pm Purchase | 2023-11-14 | 13G | CARGO Therapeutics, Inc. Common Stock CRGX | RTW Investments, LP | 5,175,832 13.400% | 5,175,832 (New Position) | Filing History |
| 2023-09-19 4:15 pm Unchanged | 2023-09-15 | 13D | Rocket Pharmaceuticals, Inc. RCKT | RTW Investments, LP | 18,188,457 20.320% | 0 (Unchanged) | Filing History |
| 2023-08-11 4:15 pm Purchase | 2023-08-01 | 13D | Allurion Technologies Inc. ALUR | RTW Investments, LP | 138,308 7.400% | 138,308 (New Position) | Filing History |
| 2023-05-10 2:24 pm Unchanged | 2023-05-09 | 13D | CUTERA INC CUTRQ | RTW Investments, LP | 1,846,596 9.300% | 0 (Unchanged) | Filing History |
| 2023-05-05 09:14 am Purchase | 2023-04-13 | 13D | Orchestra BioMed Holdings, Inc. OBIO | RTW Investments, LP | 5,620,645 15.700% | 502,133 (+9.81%) | Filing History |
| 2023-04-12 9:29 pm Purchase | 2023-04-12 | 13D | CUTERA INC CUTRQ | RTW Investments, LP | 1,846,596 9.300% | 47,921 (+2.66%) | Filing History |
| 2023-04-05 4:31 pm Sale | 2022-12-01 | 13D | Renovacor, Inc. RCOR | RTW Investments, LP | 0 0.000% | -3,350,803 (Position Closed) | Filing History |